2025-07-24 - Analysis Report
Okay, here's the analysis of Teladoc Health Inc (TDOC) based on the data you provided, presented in an English report format with numerical highlights and added analysis.

## Teladoc Health Inc (TDOC) Stock Analysis

**Ticker:** TDOC
**Company Name:** Teladoc Health Inc.
**Description:** Teladoc Health Inc. is a virtual healthcare company offering telehealth services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -64.24%
*   **VOO Cumulative Return:** 98.15%
*   **Absolute Divergence:** -162.4

TDOC has significantly underperformed the S&P 500 (VOO) over the observed period.

*   **Divergence Range:** Max: 456.6, Min: -162.6
*   **Relative Divergence:** 0.0

The current relative divergence is at the lowest end of its historical range, suggesting TDOC is currently performing at its worst relative to VOO within the analyzed period.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD   | Alpha    | Beta  | Cap(B) |
| ---------- | ------- | ----- | -------- | ----- | ------ |
| 2015-2017  | 76.0%   | 60.6% | 50.0%    | -0.0  | 6.3    |
| 2016-2018  | 128.0%  | 59.3% | 110.0%   | -0.0  | 8.9    |
| 2017-2019  | 176.0%  | 59.3% | 147.0%   | 0.4   | 15.1   |
| 2018-2020  | 237.0%  | 64.0% | 217.0%   | 0.1   | 36.0   |
| 2019-2021  | -83.0%  | 64.0% | -132.0%  | 0.1   | 16.5   |
| 2020-2022  | -295.0% | 81.3% | -297.0%  | 0.0   | 4.3    |
| 2021-2023  | -488.0% | 81.3% | -506.0%  | -0.6  | 3.9    |
| 2022-2024  | -111.0% | 81.3% | -137.0%  | -0.8  | 1.6    |
| 2023-2025  | -35.0%  | 72.9% | -84.0%   | -0.8  | 1.5    |

*   **Analysis:**
    *   **CAGR Trends:**  The Compound Annual Growth Rate (CAGR) shows a significant decline over the later periods.  The earlier periods show very strong growth, but the more recent periods (2019-2025) indicate substantial losses.
    *   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant risk and volatility. This has remained relatively stable.
    *   **Alpha:** The alpha values reflect the stock's underperformance relative to a benchmark. Early values show a good amount of outperformance, which drastically drops in later years.
    *   **Beta:** The beta values are mostly close to zero or negative. This indicates that the stock's returns are not strongly correlated with the overall market and may even move inversely to the market. The negative Beta in recent years indicate reduced systematic risk.
    *   **Cap(B):** The company's market capitalization increased in early years, but has significantly reduced more recently.
    *   In conclusion, the historical alpha and beta analysis reveals that TDOC once outperformed the market but now significantly underperforms, suggesting it could be more of a growth-oriented or risk-taking investment in the earlier days.

### 2. Recent Stock Price Movements

*   **Current Price:** 8.42
*   **Last Market Data:** Price: 8.64, Previous Close: 8.42, Change: 2.61%
*   **5-Day Moving Average:** 8.144
*   **20-Day Moving Average:** 8.2895
*   **60-Day Moving Average:** 7.5243

The recent price (8.64) is above all three moving averages, suggesting a short-term upward trend. The 2.61% change from the previous close indicates a noticeable positive movement.

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 47.20
*   **PPO:** -0.64
*   **Hybrid Signal:** cash\_69%_Sell 0.9% of holdings (14 shares - Caution - MRI:0.34)
*   **20-Day Relative Divergence Change:** 0.0 (Neutral)
*   **Expected Return (%):** -9736.8

*   **Analysis:**
    *   The MRI suggests low market risk.
    *   The RSI is close to neutral (50), indicating neither overbought nor oversold conditions.
    *   The PPO indicates that the short-term moving average is slightly below the long-term moving average, suggesting a slight downtrend or lack of strong momentum.
    *   The hybrid signal leans towards selling a small portion of holdings, with a significant cash allocation, indicating a cautious approach.
    * The large change from previous close (2.61%) signals potential volatility or reaction to recent news. The very large negative expected return should be carefully considered.

### 4. Recent News & Significant Events

*   **[2025-07-23]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-24]:** Analyst discussions of performance in the context of industry trends and global economic factors.
*   **[2025-07-20]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-21]:** Market experts highlight both risks and opportunities, advising investors to monitor news and announcements.

These recent news events suggest that TDOC is currently experiencing significant changes and volatility, warranting close monitoring.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue   |
| ---------- | ----- | --------- |
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

*   **Analysis:**
    *   The company has been consistently reporting negative EPS.
    *   Revenue has remained relatively stable around $0.63-0.65 billion. The spike in negative EPS in 2024-08-01 is particularly concerning.

### 6. Financial Information

**Revenue and Profitability**

| Quarter    | Revenue  | Profit Margin |
| ---------- | -------- | ------------- |
| 2025-03-31 | \$0.63B | 68.73%        |
| 2024-12-31 | \$0.64B | 70.50%        |
| 2024-09-30 | \$0.64B | 71.94%        |
| 2024-06-30 | \$0.64B | 70.73%        |
| 2024-03-31 | \$0.65B | 69.89%        |

**Capital and Profitability**

| Quarter    | Equity   | ROE       |
| ---------- | -------- | --------- |
| 2025-03-31 | \$1.43B | -6.52%    |
| 2024-12-31 | \$1.49B | -3.25%    |
| 2024-09-30 | \$1.51B | -2.21%    |
| 2024-06-30 | \$1.50B | -55.77%   |
| 2024-03-31 | \$2.29B | -3.58%    |

*   **Analysis:**
    *   The profit margin is relatively high, indicating strong pricing power or efficient cost management *before* accounting for all expenses.
    *   However, the negative ROE indicates that the company is not generating profits from its equity, further illustrating profitability challenges. The significant drop in equity from 2024-03-31 to later quarters and the large negative ROE in 2024-06-30 are areas of major concern.

### 7. Overall Analysis & Summary

Teladoc Health Inc. (TDOC) demonstrates a concerning financial picture based on the provided data. While revenue has been stable and profit margins appear high, the company struggles with profitability, evidenced by negative EPS and ROE. It has significantly underperformed the S&P 500, and the hybrid signal recommends a cautious approach with a high cash allocation. Recent news suggests the company is undergoing significant changes and experiencing volatility.

**Key Concerns:**

*   **Underperformance:** Significant underperformance compared to the S&P 500.
*   **Profitability:** Consistent negative EPS and ROE, indicating fundamental profitability issues.
*   **Volatility:** Recent price volatility and news events indicate uncertainty.
*   **Declining Equity:** Notable drop in equity.

**Potential Positives:**

*   **Stable Revenue:** Revenue has remained consistent.
*   **High Profit Margin:** The profit margin shows potential for profitability with better cost management.
*   **Low MRI:** Suggests that the stock carries low market risk.

**Recommendation:**

Based on this analysis, a *highly cautious* approach is warranted for TDOC. Further investigation is needed to understand the underlying causes of the negative profitability and the recent news events. Investing in TDOC at this time appears to carry a high degree of risk. The very negative expected return should be a major red flag.

**Disclaimer:** This analysis is based solely on the data provided and does not constitute financial advice. Investors should conduct thorough research and consult with a financial advisor before making any investment decisions.
